$3.120
-0.087 (-2.80%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CCCC por análisis de gráficos similares
Alphio's CCCC stock price prediction model matches the current C4 Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.14 (+0.56%). The 1-week path is $3.16 (+1.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de C4 Therapeutics Inc?
C4 Therapeutics Inc is a good buy right now, given its current price of $3.21 and a significant upside potential indicated by JPMorgan's $10 price target. Additionally, the company has shown a 66.32% year-to-date change and a 7.72% increase over the past five days, suggesting positive momentum. However, the main risk is its ongoing net losses, with a reported net loss of $23.63 million in Q2 2026.
CCCC cerró en $3.12 el Wednesday, tras bajar -2.80%
C4 Therapeutics Inc (CCCC) last closed at $3.1199999, losing -2.80%. These facts feed the 1-day and 1-week CCCC price prediction above.
Factores de la previsión
Los factores de la previsión de C4 Therapeutics Inc (CCCC) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CCCC, ordenadas por similitud.
Análisis de estacionalidad de CCCC
Historically the probability of a positive November return for CCCC is 7.14%. March offers the highest probability of a positive month at 66.67%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CCCC
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.41 | $1.75 | $2.13 | -43.76% |
| Dec 2026 | $1.66 | $1.97 | $2.05 | -36.71% |
En 2026, se proyecta que C4 Therapeutics Inc (CCCC) oscile entre $1.41 y $2.13.
Previsión mensual de C4 Therapeutics Inc para 2026
En Nov de 2026, se proyecta que C4 Therapeutics Inc promedie $1.75, con un mínimo de $1.41 y un máximo de $2.13.
En Dec de 2026, se proyecta que C4 Therapeutics Inc promedie $1.97, con un mínimo de $1.66 y un máximo de $2.05.
Artículos relacionados
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
- Democratic Sweep Sends Stocks Soaring: Dow Posts Best Post-Midterm Rally in 44 Years Amid AI Sector US stocks surged after Democrats swept the 2026 midterms. The Dow jumped 1,569 points for its best post-election day since 1982 as markets cheered political clarity.
- Stock Market Surges After 2026 Midterms: What the Democratic Sweep Means for Your PortfolioThe stock market rallied after Democrats won the 2026 midterms. Discover what the election means for investors, tech stocks, and the S&P 500 outlook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.